Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for preparing swine O-type foot-and-mouth disease synthetic peptide antigen 2800 by solid-phase fragment method

A technology for foot-and-mouth disease and synthesizing peptides, which can be applied in the fields of peptide preparation, hybrid peptides, chemical instruments and methods, etc., and can solve the problems of incomplete core sequence, wrong sequence, pollution, etc.

Active Publication Date: 2017-04-12
SHANGHAI SHEN LIAN BIOMEDICAL CORP
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although a lot of research has been done on most of the possible side reactions and their mechanisms in the past few years, the yield of a single-step cycle still cannot reach more than 99.5%, and the remaining 0.5% of each step accumulates as by-products of polluting products.
Therefore, the target peptide is easily contaminated by a series of compounds with similar structures and chemical properties, such as diastereoisomers formed by epimerization, wrong sequences and incomplete core sequences, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing swine O-type foot-and-mouth disease synthetic peptide antigen 2800 by solid-phase fragment method
  • Method for preparing swine O-type foot-and-mouth disease synthetic peptide antigen 2800 by solid-phase fragment method
  • Method for preparing swine O-type foot-and-mouth disease synthetic peptide antigen 2800 by solid-phase fragment method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] This embodiment relates to the preparation of SEQ ID No: 3 modified by 9-fluorenylmethoxycarbonyl at the amino end, which specifically includes the following steps:

[0067] (1) Preparation of Fmoc-Pro-2-chlororityl resin

[0068] Weigh 100g of 2-chlororityl resin (100-200 mesh, 1.1mmol / g, 110mmol) into the EST-50 polypeptide synthesizer, swell with 1L of DCM for 30min, filter to dryness, add 1L to dissolve 37.1g of Fmoc-Pro- OH (110mmol, 1.0eq) and 14.2g of DIEA (18.7ml, 110mmol) in DCM were reacted at 20-25°C for 60min. Filter to dryness, add 1 L of MeOH / DIEA (9:1) solution to block for 30 minutes, after filtration, the resin is washed several times with NMP, MeOH, and NMP in sequence, and then drained to obtain Fmoc-Pro-2-chlorotrityl resin. Take a small amount of resin and wash it several times with MeOH to measure the loading by removing Fmoc method, and the measured loading is 0.70mmol / g.

[0069] (2) Preparation of Fmoc-Leu-Pro-2-chlorotrityl resin

[0070] Ad...

Embodiment 2

[0076] This embodiment relates to the preparation of SEQ ID No: 4 modified by 9-fluorenylmethoxycarbonyl at the amino end, which specifically includes the following steps:

[0077] (1) Preparation of Fmoc-Gly-2-chlororityl resin

[0078] Weigh 100g of 2-chlororityl resin (100-200 mesh, 1.1mmol / g, 110mmol) into the EST-50 peptide synthesizer, swell with 1L of DCM for 30min, filter to dryness, add 1L to dissolve 32.7g of Fmoc-Gly- OH (110mmol) and 14.2g of DIEA (18.7ml, 110mmol) in DCM were reacted at 20-25°C for 60min. After filtering to dryness, add 1L of MeOH / DIEA (9:1) solution for blocking reaction for 30min. After filtering, the resin was washed several times with NMP, MeOH, and NMP in sequence, and then drained to obtain Fmoc-Gly-2-chlorotrityl resin. Take a small amount of resin and wash it several times with MeOH to measure the loading by removing Fmoc method, and the measured loading is 0.65mmol / g.

[0079] (2) Preparation of Fmoc-Arg(Pbf)-Gly-2-chlorotrityl resin

...

Embodiment 3

[0086] This embodiment relates to the preparation of SEQ ID No: 5 modified by 9-fluorenylmethoxycarbonyl at the amino end, which specifically includes the following steps:

[0087] (1) Preparation of Fmoc-Gly-2-chlororityl resin

[0088] Weigh 100g of 2-chlorotrityl resin (100-200 mesh, 1.1mmol / g, 110mmol) into the EST-50 polypeptide synthesizer, swell with 1L of DCM for 30min, filter to dryness, add 1L to dissolve 49.1g of Fmoc-Gly- OH (165mmol, 1.5eq) and 14.2g of DIEA (21.3ml, 165mmol) in DCM were reacted at 20-25°C for 60min. After filtering, add 1L of MeOH / DIEA (9:1) solution to block for 30min. After filtering, the resin was washed several times with NMP, MeOH, and NMP in sequence, and then drained to obtain Fmoc-Gly-2-chlorotrityl resin. Take a small amount of resin and wash it several times with MeOH to measure the loading by removing Fmoc method, and the measured loading is 0.80mmol / g.

[0089] (2) Preparation of Fmoc-Asn(Trt)-Gly-2-chlorotrityl resin

[0090] Add ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
Login to View More

Abstract

The invention provides a method for preparing pig O-type foot-and-mouth disease synthetic peptide antigen 2800 by using a solid-phase fragment method. The method comprises the following steps: by taking resin as an initial raw material, sequentially connecting amino acid with 9-fluorene methoxycarbonyl group protection, preparing a protected peptide fragment, sequentially removing 9-fluorene methoxycarbonyl groups in the period, performing peptide connection reaction by using a condensating agent, and cutting by using diluted acid or weak acid so as to obtain the protected peptide fragment; gradually connecting the fragment with 4-(4'-dimethoxy-9-fluorene methoxyamine methyl)-phenoxymethyl resin, and further connecting with T-auxiliary cell epitope; cutting off the protection groups and the resin by using acid so as to obtain synthetic peptide antigen 2800 coarse peptide; purifying by using ion exchange and a tangential flow membrane coating system, and concentrating to remove micromolecules and salt, thereby obtaining the synthetic peptide antigen 2800. The method provided by the invention has the characteristics of being stable in process, short in production period, convenient in obtaining raw / auxiliary materials, small in waste, low in production cost, high yield and the like.

Description

technical field [0001] The invention relates to a method for preparing swine type O foot-and-mouth disease synthetic peptide antigen 2800 by a solid-phase fragment method. Background technique [0002] The structural formula of swine type O foot-and-mouth disease synthetic peptide antigen 2800 is as follows: [0003] [0004] Pig foot-and-mouth disease is an acute, febrile, highly contagious infectious disease caused by foot-and-mouth disease virus. In recent years, foot-and-mouth disease has broken out in a large area in Jiangsu, Sichuan, the three northeast provinces and Inner Mongolia, causing huge economic losses. Currently, immunization remains the main means of controlling the disease. The traditional inactivated vaccine is still the leading method for the prevention and treatment of foot-and-mouth disease at home and abroad, but it is easy to cause side effects such as allergies, and there are also problems in biosafety. Therefore, a lot of research has been don...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K19/00C07K1/06C07K1/04
CPCY02P20/55
Inventor 姬明放张震
Owner SHANGHAI SHEN LIAN BIOMEDICAL CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products